Delivery Order SPE2DB22D2005-SPE2DB23FJRF5

Award Date 7/6/23
Potential Completion Date 7/7/23
Potential Value $77
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $33,640 delivery order to Amerisourcebergen Drug Corporation for the provision of 2 mg buprenorphine tablets. The firm fixed price order is for 30 tablets to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania to an unknown customer by July 21, 2023. As the DLA supports Department of Defense procurement and supply chain management, this small order for opioid addiction treatment medication was likely placed to support medical...
The Defense Logistics Agency awarded a $33,640 delivery order to Amerisourcebergen Drug Corporation for the supply of 2 mg buprenorphine tablets. Under this firm fixed price contract, Amerisourcebergen will deliver 30-count bottles of the tablets to a location in Conshohocken, Pennsylvania by August 21, 2023 to support Defense Logistics Agency pharmaceutical needs. No set aside designation or subcontractors were identified. This delivery order was issued against an existing DLA pharmaceutical...
The Defense Logistics Agency Troop Support Medical awarded a $3,611 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 0.3 mg/ml buprenorphine vials. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The single day order from August 22nd to 23rd, 2023 is under an existing indefinite delivery/indefinite quantity contract vehicle held by Amerisourcebergen with the agency. As a leading pharmaceutical distributor, Amerisourcebergen will...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $272.02 to Amerisourcebergen Drug Corporation for the supply of 30 units of 8-2mg films of buprenorphine-naloxone. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The order is for a single day's supply from August 1-2, 2023 under an indefinite delivery/indefinite quantity contract vehicle. As a leading pharmaceutical distributor, Amerisourcebergen will deliver these opioid...
The Defense Logistics Agency Troop Support Medical awarded a $138,900 delivery order to Amerisourcebergen Drug Corporation for Buprenorphine 0.3 mg/ml 5ml syringes. The firm fixed price order is for product delivery to a location in Conshohocken, Pennsylvania between August 2nd and August 3rd, 2023. Amerisourcebergen will fulfill the order as the prime contractor. The Defense Logistics Agency manages the Department of Defense's global supply chain and supports military treatment facilities and...
The Defense Logistics Agency Troop Support Medical awarded a $549 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 boxes containing 8 mg buprenorphine tablets. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 6, 2023 through July 7, 2023. This delivery order was issued against an existing DLA medical supply vehicle and will provide the agency with a one-day supply of an opioid addiction...
The Defense Logistics Agency Troop Support Medical awarded a $137,340 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 boxes containing 8 mg buprenorphine tablets. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 20, 2023 through July 21, 2023. No major subcontractors or set aside designations were identified. This delivery order was issued under an existing...
The Defense Logistics Agency awarded a $100,920 delivery order to Amerisourcebergen Drug Corporation for 2 mg buprenorphine tablets. Under the firm fixed price contract, Amerisourcebergen will deliver 30 boxes of the tablets to a location in Conshohocken, Pennsylvania by August 15, 2023 to support the Agency's medical supply needs. As a top supplier of pharmaceuticals and medical supplies, Amerisourcebergen is well positioned to meet the delivery order requirements on behalf of the Defense...
The Defense Logistics Agency awarded a $138,900 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 0.3 mg/ml buprenorphine vials. The single day contract has a period of performance from August 1-2, 2023, with all work to be conducted by the prime contractor at its Conshohocken, Pennsylvania facility. As the DLA supports military treatment programs, this award is likely associated with its pharmaceutical prime vendor indefinite-delivery/indefinite-quantity contract to...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at sixty-seven thousand three hundred thirty dollars to Amerisourcebergen Drug Corporation for the supply of two milligram buprenorphine tablets. Under the contract, Amerisourcebergen will deliver thirty tablets of the specified medication to a facility located in Conshohocken, Pennsylvania, with performance required between August 23rd and 24th of 2023. The prime contractor, a division of Amerisourcebergen...
  • SPE2DB22D2005
    Indefinite Delivery Contract
  • SPE2DB22D2005-SPE2DB23FJRF5
    Delivery Order

The Defense Logistics Agency awarded a $76,960 delivery order to Amerisourcebergen Drug Corporation for buprenorphine hydrochloride injection in 0.3 mg/mL vials. The firm fixed price order is being fulfilled under an existing Prime Vendor Program contract vehicle and calls for delivery to a facility in Conshohocken, Pennsylvania by July 7, 2023. As a leading distributor of pharmaceuticals and medical supplies, Amerisourcebergen will leverage its extensive distribution network to provide this opioid addiction treatment medication in support of DLA and Department of Defense needs. No subcontractors or set aside designations were specified.

Generated 12/20/23, 4:47 AM